Who owns the FLEXITAB trademark?

The FLEXITAB trademark is owned by Altus Formulation Inc..

What class is the FLEXITAB trademark registered in?

The FLEXITAB trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for FLEXITAB?

The USPTO serial number for FLEXITAB is 97783100.

What is the registration number for FLEXITAB?

FLEXITAB is registered under USPTO registration number 7940642.

Sealvo

Home Search: FLEXITABFLEXITAB #97783100

Back

Updated Sep 27, 2026·10 searches this week

View on USPTO TSDR Find similar marks

FLE

USPTO Trademark Record

REGISTERED

FLEXITAB

SN 97783100·Reg 7940642·Filed Feb 06, 2023

Owner Altus Formulation Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

FLEXITAB (Serial No. 97783100), Registration No. 7940642, is a registered US trademark filed on Feb 06, 2023 by Altus Formulation Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: September 09, 2031

Conflict Analysis

Full conflict analysis for FLEXITAB (SN 97783100) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

FLEXITAB (Reg. #7940642) is a registered US trademark that has been protecting its owner, Altus Formulation Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 06, 2023

SERIAL

97783100

REG#

7940642

REGISTERED

Sep 09, 2025

Filing Information

StatusREGISTERED

Filing DateFeb 06, 2023

Serial Number97783100

Registration No.7940642

Registration DateSep 09, 2025

Status DateSep 09, 2025

Published for OppositionMar 12, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 31, 2015

First use in commerce: Jan 31, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Sep 09, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 09, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 20, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 20, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Aug 05, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Nov 07, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 07, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 07, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 12, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 12, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 21, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 21, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 07, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 06, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 06, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 06, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 07, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 07, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 07, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 02, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 25, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 09, 2023

NEW APPLICATION ENTERED

Other Marks by Altus Formulation Inc.

Additional USPTO filings from the same owner.

AMY

AMYLOFLEX

97782776

Altus Formulation Inc.

PENDING

Other Marks by Alison M. Caless

Additional USPTO filings handled by the same attorney of record.

HOR

HORA

79001809

REGISTERED

OCW

O.C. WHITE

78736362

REGISTERED

VIS

VISION-LITE

78787553

REGISTERED

PRO

PROBOOM

78969917

REGISTERED

FLEXITAB

Run a conflict check

Other Marks by Altus Formulation Inc.

Other Marks by Alison M. Caless

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company